about
Pre-admission antibiotics for suspected cases of meningococcal diseaseAntibiotics for preventing meningococcal infectionsAntibiotics for preventing meningococcal infectionsPre-admission antibiotics for suspected cases of meningococcal diseaseAntibiotics for preventing meningococcal infectionsPre-admission antibiotics for suspected cases of meningococcal diseaseSerogroup W-135 meningococcal disease during the Hajj, 2000Prospects for vaccine prevention of meningococcal infectionPathogen recognition and inflammatory signaling in innate immune defensesStructural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086Bench-to-bedside review: genetic influences on meningococcal diseaseAn unusual case of chronic meningitisDrotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.Meningococcal VaccinationsEstimates of the burden of meningococcal disease in Italy: implications for prevention and controlRole of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseImportance of circulating antibodies in protection against meningococcal diseaseMeningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal diseaseNeurologic Aspects of Infections in International TravelersThe structure of a reduced form of OxyR from Neisseria meningitidisN. meningitidis 1681 is a member of the FinO family of RNA chaperonesCrystal Structure of Outer Membrane Protein NMB0315 from Neisseria meningitidisStructure ofNeisseria meningitidislipoprotein GNA1162Neisseria meningitidisexpresses a single 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase that is inhibited primarily by phenylalanineHost-pathogen interactions in bacterial meningitisPrevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infectionNeisseria meningitidis has two independent modes of recognizing its human receptor CEACAM1Household air pollution and the lung microbiome of healthy adults in Malawi: a cross-sectional studyNeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidisFactors contributing to the immunogenicity of meningococcal conjugate vaccinesReview of meningococcal vaccines with updates on immunization in adultsCytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidisInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyThe zinc-responsive regulon of Neisseria meningitidis comprises 17 genes under control of a Zur element.Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies.Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United StatesBurden of Neisseria meningitidis infections in China: a systematic review and meta-analysis.Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Meningococcal B vaccination: real-world experience and future perspectives.Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period.
P2860
Q24200590-0471CA1A-492F-4EC5-882B-04CE18D8C397Q24202905-67C4B42F-AE3D-4797-A070-17CFC17CA008Q24235036-ECAEAB3D-116D-491C-A561-28DA369BE0D9Q24242705-CAE1A2B0-861D-4773-A4D0-44A298E81171Q24243847-9D8AD7AA-50F0-47E7-BD60-3E54D93FC766Q24246739-6ABF8C27-9677-4633-9650-69DB59DB77F6Q24290784-22F8A85F-F8DE-4A84-B6DA-68A7043AAF05Q24537338-0A165D8C-0AB5-43F8-81C7-EC631C29A594Q24643034-CBD17DC4-FD0D-4FF4-B0DA-810397FB5A62Q24654235-AF08DAB7-F572-41DE-B601-788EED38C55EQ24798186-545AE464-204F-4F4E-BABB-B686F0F2EDE5Q24806018-DE2686D1-062C-4B8B-AF9C-CE7E100C8DA6Q24810495-6D4A87A1-5064-416B-BB34-BE5A5B1636DCQ26752993-AC6BD3D5-A43D-46CB-9D7D-5BFB7B6BE651Q26770711-416AB596-CC9D-4606-A3C5-68E94A0F98FEQ26995760-602932DB-0D3B-4DAA-B773-FD670FA62CD5Q27023516-5BDA01E2-BF9D-4EC9-A40D-DFAD8D15BAFCQ27028161-5ECEB84B-A44C-4CAE-BF73-8197E0D0A205Q27488363-7622DC11-CA1E-4468-9A1B-C7677058D66BQ27661691-4EB73539-8510-4D44-BF91-BA493B0CCCECQ27665568-F9558AE8-79A0-405E-85B0-624DB02DDAE3Q27675346-EE06D462-3317-4EE8-A36C-BF9B100DBEEFQ27677157-CCC5C96E-0BBA-4A87-93A9-E1679C4AE292Q27678569-D6860854-A8E7-48D2-8202-DE1AFD352293Q28077430-381E4F68-2F99-4A4D-B60E-01813896A24EQ28080522-220E589D-0172-412F-98B4-4A96178F2022Q28476832-BA2E475C-1C4D-4ADF-89A4-F4A5198033E8Q28597911-9060C2EE-70C2-43CC-92B2-AB11878F018BQ28749761-90B00569-084A-40CC-9E76-640706E146E2Q28828544-E7228AB5-BF76-4A5D-98CA-AC8EE7872435Q28828692-FD824CC0-A7E1-464F-A7F4-168FF90AB6A3Q28903782-A88B90BE-0FF7-4BC7-9613-C5CE3ECE128EQ28972389-3B8BE975-E01C-4BDC-A135-680529D3D79CQ29346569-0CED8612-7022-4888-919A-8F83AC68D53EQ30164390-499C735F-0767-4A78-8F12-4D992F949247Q30235072-5D92322E-8653-4E97-A602-BE30CA74E2F3Q30240302-023B56B2-2C5C-44F4-BE15-D86E806F55E7Q30248749-073B6BD0-15EA-4471-A922-46861A52C0BEQ30249575-E1085589-04BC-4F99-A824-98574673BC70Q30833747-B9F5681D-DA1F-4541-BC44-5856418D8925
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Meningococcal disease.
@ast
Meningococcal disease.
@en
Meningococcal disease.
@nl
type
label
Meningococcal disease.
@ast
Meningococcal disease.
@en
Meningococcal disease.
@nl
prefLabel
Meningococcal disease.
@ast
Meningococcal disease.
@en
Meningococcal disease.
@nl
P2093
P1476
Meningococcal disease.
@en
P2093
Perkins BA
Rosenstein NE
Stephens DS
P304
P356
10.1056/NEJM200105033441807
P407
P577
2001-05-01T00:00:00Z